Yakira Capital Management, Inc. - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 43 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 5.04 and the average weighting 0.3%.

Quarter-by-quarter ownership
Yakira Capital Management, Inc. ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$667,275
-15.4%
54,118
-15.6%
0.18%
-13.4%
Q2 2023$788,651
-11.0%
64,118
-11.1%
0.21%
-7.1%
Q1 2023$886,330
-9.8%
72,118
-15.9%
0.22%
+12.5%
Q4 2022$982,489
+126.4%
85,732
-26.0%
0.20%
+217.5%
Q3 2022$434,000
-37.0%
115,8210.0%0.06%
-41.7%
Q2 2022$689,000
+22.8%
115,821
+30.6%
0.11%
+35.0%
Q1 2022$561,000
+95.5%
88,683
+20.7%
0.08%
+122.2%
Q4 2021$287,000
-2.0%
73,450
+21.1%
0.04%
-20.0%
Q3 2021$293,000
-24.3%
60,6340.0%0.04%
-28.6%
Q2 2021$387,000
+1.6%
60,6340.0%0.06%
-18.2%
Q1 2021$381,000
-8.9%
60,6340.0%0.08%
-23.0%
Q4 2020$418,000
+56.0%
60,634
-9.4%
0.10%
+26.6%
Q3 2020$268,000
+20.2%
66,9340.0%0.08%
-21.0%
Q2 2020$223,000
+54.9%
66,9340.0%0.10%
+100.0%
Q1 2020$144,000
-31.8%
66,9340.0%0.05%
-19.4%
Q4 2019$211,000
-29.9%
66,9340.0%0.06%
-29.5%
Q3 2019$301,000
-25.7%
66,9340.0%0.09%
+11.4%
Q2 2019$405,000
-12.9%
66,9340.0%0.08%
-40.6%
Q1 2019$465,000
+80.2%
66,9340.0%0.13%
+52.9%
Q4 2018$258,000
-27.7%
66,9340.0%0.09%
+27.9%
Q3 2018$357,000
+8.5%
66,9340.0%0.07%
-15.0%
Q2 2018$329,000
-45.1%
66,934
-10.1%
0.08%
-41.6%
Q1 2018$599,000
-30.4%
74,434
-11.4%
0.14%
-50.7%
Q4 2017$861,000
+284.4%
83,969
+445.0%
0.28%
+270.7%
Q3 2017$224,00015,4070.08%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
Western Standard LLC 1,894,013$23,353,18021.09%
Newtyn Management, LLC 1,873,694$23,102,6475.70%
Sio Capital Management, LLC 288,466$3,556,7861.10%
Madison Avenue Partners, LP 553,085$6,819,5380.97%
WITTENBERG INVESTMENT MANAGEMENT, INC. 209,739$2,5860.95%
Indaba Capital Management, L.P. 136,802$1,686,7690.50%
Sepio Capital, LP 306,680$3,781,3640.33%
Yakira Capital Management, Inc. 54,118$667,2750.18%
Centiva Capital, LP 187,803$2,315,6110.05%
FIFTH LANE CAPITAL, LP 10,929$134,4270.05%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders